Medici Brands Valuation | $2.25B Funding Deal Analysis

Medici Brands Hits New Valuation Milestone

Medici Brands, the parent company behind the popular David protein bar line, secured $250 million in a new funding round. This latest capital injection brings the firm to a $2.25 billion valuation. It represents a three-fold increase in value compared to their standing just one year ago. The company currently projects annual revenue to exceed $300 million for 2026.

Peter Rahal, the founder and chief executive officer of Medici Brands, stated the company plans to deploy this capital toward scaling new food brands. The strategy focuses on low-calorie and low-sugar alternatives. One recent addition to the portfolio is HallPass, a low-sugar candy brand that hit the market in late August. These products rely on EPG, a specialized fat alternative designed to maintain flavor profiles while keeping calorie counts low. This specific ingredient remains central to the company’s product development trajectory.

Market Shifts and Investor Confidence

The funding round drew participation from prominent firms including Valor Equity Partners and Greenoaks. Imaginary Ventures and ICONIQ also joined the deal. This influx of capital counts as one of the largest private sector investments for a food-based business in recent years. It signals strong confidence in the snack food sector, particularly as consumer habits shift toward health-conscious dietary choices.

Demand for high-protein, low-sugar snacks has grown steadily as GLP-1 weight-loss medications change broader consumption patterns. Medici Brands has worked to capture this segment by placing David bars in over 35,000 retail outlets. Beyond the core bar product, the company has expanded into high-protein ice cream and protein shakes to diversify its reach.

Operational Hurdles and Future Outlook

Expansion has not been without its logistical challenges. In 2025, Medici Brands moved to acquire Epogee, the manufacturer of EPG, to protect its supply chain. Previous supply constraints had forced the company to struggle with production demand. Rahal invested $20 million of his own capital into this latest funding cycle, underscoring his commitment to the firm’s long-term scale. The business previously secured $75 million in May 2025.

Public scrutiny has accompanied the brand’s rapid growth. EPG was the subject of a class-action lawsuit earlier this year, which alleged the company misled consumers regarding fat and calorie content. The litigation was dropped in March after the brand defended its labeling practices as consistent with established US food standards. Looking ahead, the company intends to maintain its focus on product development. Whether this model can withstand continued regulatory and legal pressures remains an open question for industry observers.